Holoprosencephaly

Joseph R Siebert PhD (Dr. Siebert of the University of Washington has no relevant financial relationships to disclose.)
Harvey B Sarnat MD FRCPC MS, editor. (Dr. Sarnat of the University of Calgary has no relevant financial relationships to disclose.)
Originally released October 21, 1994; last updated August 18, 2016; expires August 18, 2019

Overview

In this updated review of holoprosencephaly, the author discusses basic diagnostic anatomical features, pathogenetic and etiologic factors, as well as genetic, epidemiologic, and other data essential to understanding this complex disorder. Research indicates that the diverse phenotypic variations may stem from a host of genetic mutations and is further suggestive of gene-environment interactions. In severe forms, the disease is lethal. The treatment of patients with less severe forms continues to be refined, but can be substantial.

Key points

 

• Holoprosencephaly is the most common congenital malformation to affect the forebrain and face in liveborn infants.

 

• In its most severe forms, holoprosencephaly is lethal; in milder forms, prolonged survival is possible but may require specialized, long-term care.

 

• Causes are diverse and include teratogens (maternal diabetes mellitus, ethyl alcohol), chromosomal abnormalities (most often trisomy 13), and gene mutations (most commonly SHH, SIX3, ZIC2, and TGIF), with gene-environmental interactions hypothesized.

Historical note and terminology

The earliest references to holoprosencephaly were from ancient mythology and generally involved cyclopic individuals. A race of fanciful, one-eyed people, the Arimaspi, was referred to in the times of Herodotus, Pliny, and St. Augustine.

These writings presumably had a basis in fact, for cyclopia occurs naturally in humans and a variety of animals. During the 16th and 17th centuries, several of the natural philosophers described cyclopic individuals, but these were still pictured with both real and imaginary features. The late 18th and 19th centuries brought more accurate portrayals. Sommering's atlas contains a precise line drawing of a full-term hydrocephalic cranium with a rudimentary, single nostril nose; olfactory nerves were absent (Sommering 1791). In 1832, Isidore Geoffrey Saint-Hilaire produced a detailed if somewhat arbitrary morphological classification of holoprosencephaly, the "cyclocephalians," whose details remain largely valid today (Geoffrey Saint-Hilaire 1832; Souza et al 1990). Taruffi reworked Geoffrey Saint-Hilaire's scheme, using a now defunct term, "hypoproso-aplasia" (Taruffi 1891).

By the late 19th century, the external facial features of holoprosencephaly were well documented. The first experimental production of holoprosencephaly was by Dareste (Dareste 1877), and in 1882 Kundrat described the cerebral changes of holoprosencephaly, including absent olfactory nerves, coining the term "arrhinencephaly" (Kundrat 1882).

The 20th century brought further developments, first in the anatomic and clinical delineation of the disorder and later in cytogenetics. Yakovlev used the term "holotelencephaly" to describe a cerebrum that had failed to develop into separate hemispheres (Yakovlev 1959). DeMyer and Zeman first used the term "holoprosencephaly," feeling that the word more accurately described the anomaly as being prosencephalic rather than telencephalic in origin and scope (DeMyer and Zeman 1963). DeMyer and Cohen steadfastly contributed to the clinical understanding of the disorder, and Siebert and colleagues added to the fund of morphologic knowledge. Munke (or Muenke) and colleagues have extended the genetic understanding of this disorder considerably, mapping several genes associated with holoprosencephaly (Munke et al 1995; Roessler and Muenke 2010).

The content you are trying to view is available only to logged in, current MedLink Neurology subscribers.

If you are a subscriber, please log in.

If you are a former subscriber or have registered before, please log in first and then click select a Service Plan or contact Subscriber Services. Site license users, click the Site License Acces link on the Homepage at an authorized computer.

If you have never registered before, click Learn More about MedLink Neurology  or view available Service Plans.